4.5 Review

Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines

期刊

HYPERTENSION RESEARCH
卷 43, 期 12, 页码 1344-1351

出版社

SPRINGERNATURE
DOI: 10.1038/s41440-020-0508-z

关键词

Hypertension; Blood pressure; Prevalence; Epidemiology; Japan

资金

  1. Ministry of Health, Labor and Welfare under Japanese Association for Cerebro-cardiovascular Disease Control [NIPPON DATA80/90/2010]
  2. Research Grant for Cardiovascular Diseases from the Ministry of Health, Labor and Welfare [7A-2]
  3. Health and Labor Sciences Research Grant, Japan (Comprehensive Research on Aging and Health) [H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014]
  4. Health and Labor Sciences Research Grant, Japan (Comprehensive Research on LifeStyle Related Diseases including CVDs and Diabetes Mellitus) [H22-Junkankitou-Seishuu-Sitei-017, H25-Junkankitou-Seishuu-Sitei-022, H30-Junkankitou-Seishuu-Sitei-002]

向作者/读者索取更多资源

From the national surveys of Japan over a 55-year period (1961-2016), a steady decrease was observed in systolic blood pressure (BP) levels among all age groups of men and women, but not in diastolic BP levels-particularly among men. Hypertension prevalence remains high: over 60% of men aged >= 50 years and women aged >= 60 years had hypertension in 2016. However, the control rates of hypertension have continuously improved over a 36-year period, and were similar to 40% in 2016. Nonetheless, the over 50% prevalence of uncontrolled hypertension is a major risk factor for future cardiovascular diseases. Of the estimated 43 million hypertensives in Japan, most (31 million, 72%) were under poor control. According to new Japanese hypertension guidelines (JSH 2019), there will be only a small increase (2.2 million, 2.1 percentage points) in adults who are recommended for antihypertensive medication compared with 2014 guidelines. However, an additional 5.3 million (22.1 percentage points) adults taking antihypertensive medication would have a BP above the target defined by JSH 2019. The number of hypertensives with poor control was targeted to decrease by 7 million-from 31 million in 2017 to 24 million in 2028-when the followings are achieved: (1) the prevalence of hypertension decreases by 5 percentage points; (2) the treatment rate of hypertension among hypertensives increases by 10 percentage points; and (3) the control rate of hypertension, defined as BP <140/90 mmHg, among individuals taking antihypertensive medication increases by 10 percentage points. Both high-risk and population strategies to manage and prevent hypertension deserve greater priority.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据